Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
KOOL [NASD]
ThermoGenesis Corp.
Index- P/E- EPS (ttm)-0.45 Insider Own30.50% Shs Outstand32.58M Perf Week-5.70%
Market Cap48.54M Forward P/E- EPS next Y- Insider Trans3.98% Shs Float22.77M Perf Month-23.20%
Income-7.40M PEG- EPS next Q- Inst Own8.00% Short Float6.39% Perf Quarter37.96%
Sales17.20M P/S2.82 EPS this Y36.70% Inst Trans85.19% Short Ratio0.86 Perf Half Y44.66%
Book/sh0.58 P/B2.57 EPS next Y- ROA-43.10% Target Price4.25 Perf Year79.52%
Cash/sh0.07 P/C21.11 EPS next 5Y- ROE-59.70% 52W Range0.71 - 3.24 Perf YTD46.08%
Dividend- P/FCF- EPS past 5Y22.00% ROI-22.60% 52W High-54.01% Beta1.12
Dividend %- Quick Ratio1.70 Sales past 5Y-3.80% Gross Margin36.00% 52W Low109.86% ATR0.13
Employees66 Current Ratio2.70 Sales Q/Q-6.30% Oper. Margin-43.00% RSI (14)35.84 Volatility8.51% 7.85%
OptionableNo Debt/Eq0.00 EPS Q/Q-233.30% Profit Margin-43.00% Rel Volume0.23 Prev Close1.42
ShortableYes LT Debt/Eq0.00 EarningsFeb 10 Payout- Avg Volume1.69M Price1.49
Recom2.00 SMA20-12.48% SMA50-24.35% SMA2009.85% Volume393,622 Change4.93%
16-Apr-14 09:21AM  Cesca Therapeutics restructures sales and marketing section at theflyonthewall.com
09:10AM  Cesca Therapeutics Announces Sales & Marketing Organizational Restructuring and the Appointment of Industry Veteran Tim Lee as Director of International Sales GlobeNewswire
06:00AM  CESCA THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
26-Mar-14 09:15AM  Cesca Therapeutics submits pre-IDE information package to FDA for SurgWerks theflyonthewall.com
09:00AM  Cesca Therapeutics Submits pre-IDE Information Package to FDA for Surgwerks(TM) CLI therapy System GlobeNewswire
18-Mar-14 09:00AM  Cesca Therapeutics to Present at Regen Med Investor Day March 26 in New York GlobeNewswire
05-Mar-14 05:07PM  CESCA THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
03-Mar-14 09:15AM  Cesca Therapeutics Appoints Dr. Mahendra Rao to Board of Directors GlobeNewswire
26-Feb-14 01:04PM  CESCA THERAPEUTICS INC. Financials EDGAR Online Financials
24-Feb-14 09:00AM  Cesca Therapeutics and Cook Medical Enter Supply Agreement for a Phase 1b Clinical Trial GlobeNewswire
22-Feb-14 01:04PM  CESCA THERAPEUTICS INC Financials EDGAR Online Financials
21-Feb-14 04:57PM  CESCA THERAPEUTICS INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Unregistered Sale of EDGAR Online -5.14%
20-Feb-14 01:04PM  THERMOGENESIS CORP Financials EDGAR Online Financials +11.45%
19-Feb-14 07:30AM  Cesca Therapeutics Inc., Formerly ThermoGenesis Corp., Closes Merger With TotipotentRX Corporation and Changes Name GlobeNewswire
06:01AM  THERMOGENESIS CORP Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
17-Feb-14 08:29PM  ThermoGenesis' CEO Discusses F2Q2014 Results - Earnings Call Transcript at Seeking Alpha
08:29PM  ThermoGenesis' CEO Discusses F2Q2014 Results - Earnings Call Transcript
14-Feb-14 04:23PM  THERMOGENESIS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online -5.65%
04:00PM  ThermoGenesis Corp. Reports Second Quarter Fiscal 2014 Results GlobeNewswire
13-Feb-14 01:50PM  ThermoGenesis Corp. Stockholders Approve Acquisition of TotipotentRX GlobeNewswire +6.48%
11-Feb-14 09:00AM  ThermoGenesis Corp. to Announce Second Quarter Fiscal 2014 Results on February 14, 2014 GlobeNewswire -6.50%
10-Feb-14 02:42PM  Cesca Merger Imminent: Path To 2x+ Returns Appears Achievable at Seeking Alpha +11.82%
05-Feb-14 09:55AM  Thermogenesis Corporation (KOOL) Is Today's Dead Cat Bounce Stock at TheStreet
03-Feb-14 09:20AM  TotipotentRX and ThermoGenesis Achieve Bone Marrow Stem Cell Transplant Milestone GlobeNewswire
30-Jan-14 04:22PM  THERMOGENESIS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securi EDGAR Online
04:22PM  THERMOGENESIS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securi
27-Jan-14 09:24AM  Thermogenesis raises $6.67M in a private placement theflyonthewall.com -13.12%
09:24AM  Thermogenesis raises $6.67M in a private placement
09:00AM  ThermoGenesis Corp. Raises $6.67 Million in Private Placement Financing GlobeNewswire
09:00AM  ThermoGenesis Corp. Raises $6.67 Million in Private Placement Financing
22-Jan-14 12:43PM  Has ThermoGenesis Peaked? at 24/7 Wall St. +14.35%
12:43PM  Has ThermoGenesis Peaked?
21-Jan-14 03:33PM  ThermoGenesis Merging With TotiRx - Heating Up Cell Therapy Mergers And Acquisitions at Seeking Alpha +111.01%
03:33PM  ThermoGenesis Merging With TotiRx - Heating Up Cell Therapy Mergers And Acquisitions
09:00AM  TotipotentRX Corporation and ThermoGenesis Corp. Report Statistically Significant Phase Ib Clinical Trial Results in Critical Limb Ischemia GlobeNewswire
09:00AM  TotipotentRX Corporation and ThermoGenesis Corp. Report Statistically Significant Phase Ib Clinical Trial Results in Critical Limb Ischemia
17-Jan-14 09:47AM  THERMOGENESIS CORP Files SEC form 8-K, Other Events EDGAR Online
09:47AM  THERMOGENESIS CORP Files SEC form 8-K, Other Events
08-Jan-14 09:00AM  ThermoGenesis Signs Direct Supply Agreement With Cord Blood Registry GlobeNewswire +7.62%
09:00AM  ThermoGenesis Signs Direct Supply Agreement With Cord Blood Registry
07-Jan-14 05:00PM  THERMOGENESIS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
05:00PM  THERMOGENESIS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
24-Dec-13 06:47AM  Who Will Win The Stem Cell Race? at Seeking Alpha +31.58%
23-Dec-13 12:00PM  ThermoGenesis Announces Bebevida Agreement GlobeNewswire +5.56%
12:00PM  ThermoGenesis Announces Bebevida Agreement
13-Dec-13 05:27PM  THERMOGENESIS CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard EDGAR Online
05:27PM  THERMOGENESIS CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
27-Nov-13 05:18PM  THERMOGENESIS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
05:18PM  THERMOGENESIS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
21-Nov-13 01:04PM  THERMOGENESIS CORP Financials EDGAR Online Financials
01:04PM  THERMOGENESIS CORP Financials
14-Nov-13 08:12PM  ThermoGenesis' CEO Discusses F1Q 2014 Results - Earnings Call Transcript at Seeking Alpha
08:12PM  ThermoGenesis' CEO Discusses F1Q 2014 Results - Earnings Call Transcript
04:42PM  THERMOGENESIS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
04:42PM  THERMOGENESIS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
04:00PM  ThermoGenesis Reports First Quarter Fiscal 2014 Results GlobeNewswire
04:00PM  ThermoGenesis Reports First Quarter Fiscal 2014 Results
07:08AM  Q1 2014 Thermogenesis Earnings Release - After Market Close CCBN
07:08AM  Q1 2014 Thermogenesis Earnings Release - After Market Close
08-Nov-13 04:06PM  ThermoGenesis Corp. to Announce First Quarter Fiscal 2014 Results on November 14, 2013 GlobeNewswire
31-Oct-13 12:28PM  THERMOGENESIS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
30-Oct-13 04:00PM  InPlay: Thermogenesis announces strategic reorganization initiative Briefing.com
04:00PM  ThermoGenesis Announces Strategic Reorganization Initiative GlobeNewswire
11:13AM  THERMOGENESIS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
14-Oct-13 09:01AM  InPlay: Thermogenesis' TotipotentRX & ThermoGenesis case study demonstrates autologous stem cell product safely treats primary heart attack in 60 minute clinical procedure Briefing.com +8.74%
09:00AM  TotipotentRX & ThermoGenesis Case Study Demonstrates Autologous Stem Cell Product Safely Treats Primary Heart Attack in 60 Minute Clinical Procedure GlobeNewswire
10-Oct-13 09:05AM  InPlay: Thermogenesis and TotipotentRX to present clinical data at the AABB conference; presentation on AMIRST acute myocardial infarction study and pediatric allogeneic mismatched bone marrow transplant program Briefing.com
09:00AM  TotipotentRX and ThermoGenesis to Present Clinical Data at the AABB Conference GlobeNewswire
07-Sep-13 01:04PM  THERMOGENESIS CORP Financials EDGAR Online Financials
04-Sep-13 06:01AM  THERMOGENESIS CORP Files SEC form 10-K, Annual Report EDGAR Online
03-Sep-13 09:00AM  ThermoGenesis to Present at the Rodman & Renshaw(R) Annual Global Investment Conference GlobeNewswire
29-Aug-13 08:32PM  ThermoGenesis Corp's CEO Discusses F4Q 2013 Results - Earnings Call Transcript at Seeking Alpha
05:03PM  THERMOGENESIS CORP Files SEC form 8-K, Termination of a Material Definitive Agreement, Results of Operations and Fina EDGAR Online
04:05PM  ThermoGenesis Reports Fourth Quarter and Full Fiscal Year 2013 Results GlobeNewswire
07:07AM  Q4 2013 Thermogenesis Earnings Release - After Market Close CCBN
27-Aug-13 09:30AM  ThermoGenesis Corp. to Announce Fourth Quarter and Fiscal 2013 Year End Results on August 29, 2013 GlobeNewswire
08-Aug-13 07:00AM  TotipotentRX and ThermoGenesis Announce Successful Launch of Bone Marrow Transplant Program GlobeNewswire +17.95%
01-Aug-13 09:07AM  THERMOGENESIS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
24-Jul-13 05:06PM  Two Medical Device Companies Making Smart Acquisitions at Motley Fool
18-Jul-13 09:17AM  THERMOGENESIS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
17-Jul-13 01:35AM  THERMOGENESIS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
16-Jul-13 11:38AM  ThermoGenesis to combine with TotipotentRx AP -15.44%
10:49AM  Apple Eyes New Acquisition, Rio Tintos Production Ramp, and 3 More Hot Stocks at Wall St. Cheat Sheet
07:02AM  InPlay: Thermogenesis and TotipotentRx announce definitive merger agreement; KOOL will issue ~ 12,491,000 shares of its common stock to TotiRx which equates to a value of ~ $18.6 mln, based on KOOL's closing stock price on July 15, 2013 Briefing.com
07:00AM  ThermoGenesis and TotipotentRx Announce Definitive Merger Agreement GlobeNewswire
15-Jul-13 11:03PM  THERMOGENESIS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements EDGAR Online
12-Jun-13 08:00AM  ThermoGenesis Announces New AXP(R) Customer in the United Kingdom GlobeNewswire
10-Jun-13 06:39AM  THERMOGENESIS CORP Files SEC form 8-K, Other Events EDGAR Online
29-May-13 07:01PM  Nasdaq stocks posting largest volume increases AP
28-May-13 06:02PM  Nasdaq stocks posting largest volume increases AP
09:37AM  THERMOGENESIS CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
24-May-13 06:04PM  Nasdaq stocks posting largest volume increases AP +10.00%
21-May-13 01:04PM  THERMOGENESIS CORP Financials EDGAR Online Financials +6.90%
14-May-13 09:13PM  ThermoGenesis' CEO Discusses F3Q2013 Results - Earnings Call Transcript at Seeking Alpha +5.56%
04:05PM  ThermoGenesis Reports Third Quarter Fiscal 2013 Results GlobeNewswire
09:38AM  THERMOGENESIS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
07:07AM  Q3 2013 Thermogenesis Earnings Release - After Market Close CCBN
08-May-13 04:38PM  InPlay: Thermogenesis announces registration approval of AXP in China; major milestone as a first mover in China for the automation of cord blood processing Briefing.com
04:05PM  ThermoGenesis Announces Registration Approval of AXP in China GlobeNewswire
07-May-13 09:00AM  ThermoGenesis Corp. to Announce Third Quarter Fiscal 2013 Results on May 14, 2013 GlobeNewswire
Cesca Therapeutics Inc. designs, develops, and commercializes devices and disposable tools for the processing, storage, and administration of cell therapies. It provides automated and semi-automated devices, and single-use processing disposables that enable hospitals and blood banks to manufacture a therapeutic dose of stem cells. The company offers the AXP System, a medical device that isolates and retrieves stem cells from umbilical cord blood; the BioArchive System, a robotic cryogenic medical device used to cryopreserve and archive stem cells for transplant and treatment; Res-Q 60 BMC, a device used for the isolation and extraction of specific stem cell populations from bone marrow; the MarrowXpress or MXP System that isolates and concentrates stem cells from bone marrow; and Res-Q 60 PRP, which is used for the preparation of autologous platelet rich plasma from a sample of blood at the point of care. It was formerly known as ThermoGenesis Corp. and changed its name to Cesca Therapeutics Inc. in February 2014. The company was founded in 1986 and is headquartered in Rancho Cordova, California.